Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

LFVN - LifeVantage Corporation Latest News | Finranks

Home

LFVN

L

LifeVantage Corporation (LFVN)

NCM – Real Time Price. Currency in USD

4.30

+0.01 (0.23%)

At close: Mar 27, 2026, 4:00 PM EDT

4.30

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

LifeVantage to Participate in the Sidoti Small Cap Conference

LifeVantage to Participate in the Sidoti Small Cap Conference

SALT LAKE CITY, March 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Sidoti Small Cap Conference, to be held March 18-19, 2026. Mr. Fife and Mr.

LifeVantage Corporation (LFVN) Q2 2026 Earnings Call Transcript

LifeVantage Corporation (LFVN) Q2 2026 Earnings Call Transcript

LifeVantage Corporation (LFVN) Q2 2026 Earnings Call Transcript

Lifevantage (LFVN) Q2 Earnings and Revenues Lag Estimates

Lifevantage (LFVN) Q2 Earnings and Revenues Lag Estimates

Lifevantage (LFVN) came out with quarterly earnings of $0.15 per share, missing the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.22 per share a year ago.

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend

SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid March 16, 2026 to all stockholders of record at the close of business on March 2, 2026.

LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan

LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan

SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, today announced that after nine years at LifeVantage, Steve Fife, President, Chief Executive Officer and a member of the Board of Directors (the “Board”), has decided to retire in April, 2026. Fife will continue in his role as President and Chief Executive Officer during the transition period to ensure business continuity through his retirement date. The Board is conducting an extensive executive search and anticipates announcing the new CEO in the coming months.

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2025. Second Quarter Fiscal 2026 Summary*: Revenue was $48.9 million, a decrease of 27.8% from the prior year period.

Overlooked Stock: LIF 20% Rally on Boosted Guidance

Overlooked Stock: LIF 20% Rally on Boosted Guidance

Boosted sales guidance in Life360's (LIF) earnings offered a more than 20% rally for a stock that was initially down more than 50% from its 2025 high. George Tsilis explains how the company gained traction in the U.S. and abroad to back its new financial trajectory.

Videos

Overlooked Stock: LIF 20% Rally on Boosted Guidance

Press releases

LifeVantage to Participate in the Sidoti Small Cap Conference

LifeVantage to Participate in the Sidoti Small Cap Conference

SALT LAKE CITY, March 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Sidoti Small Cap Conference, to be held March 18-19, 2026. Mr. Fife and Mr.

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend

SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid March 16, 2026 to all stockholders of record at the close of business on March 2, 2026.

LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan

LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan

SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, today announced that after nine years at LifeVantage, Steve Fife, President, Chief Executive Officer and a member of the Board of Directors (the “Board”), has decided to retire in April, 2026. Fife will continue in his role as President and Chief Executive Officer during the transition period to ensure business continuity through his retirement date. The Board is conducting an extensive executive search and anticipates announcing the new CEO in the coming months.

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2025. Second Quarter Fiscal 2026 Summary*: Revenue was $48.9 million, a decrease of 27.8% from the prior year period.